1600846

Repaglinid-verwandte Verbindung C

United States Pharmacopeia (USP) Reference Standard

• Synonym(e): (S)-2-Ethoxy-4-[2-oxo -2-[[2-phenyl-1-[2-(1-piperidinyl)-phenyl]-ethyl]-amino]-ethyl]-benzoesäure
• Empirische Formel (Hill-System): C₃₀H₃₄N₂O₄
• CAS-Nummer: 1803084-79-8
• Molekulargewicht: 486.60
• MDL number: MFCD27965890
• NACRES: NA.24
• UNSPSC Code: 41116107

Eigenschaften

• grade: pharmaceutical primary standard
• agency: USP
• API family: repaglinide
• manufacturer/tradename: USP
• application(s): pharmaceutical (small molecule)
• format: neat

Beschreibung

General description

This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia.
For further information and support please go to the website of the issuing Pharmacopoeia.

Application

Repaglinide Related Compound C USP reference standard, intended for use in specified quality tests and assays as specified in the USP compendia. Also, for use with USP monograph such as Repaglinide

Analysis Note

These products are for test and assay use only. They are not meant for administration to humans or animals and cannot be used to diagnose, treat, or cure diseases of any kind.  ​

Other Notes

Sales restrictions may apply.

Sicherheitshinweise

• pictograms: GHS06
• signalword: Danger
• hcodes: H301
• pcodes: P301 + P330 + P331 + P310
• Hazard Classifications: Acute Tox. 3 Oral
• Lagerklasse: 6.1C - Combustible acute toxic Cat.3 / toxic compounds or compounds which causing chronic effects
• wgk: WGK 3
• flash_point_f: Not applicable
• flash_point_c: Not applicable